IGM Biosciences Inc (IGMS) — Free Cash Flow Generation Index
Latest as of June 2022:
0.98x
IGM Biosciences Inc (IGMS) has a Free Cash Flow Generation Index of 0.98x as of June 2022. Free cash flow of $109.46 Million represents 1% of operating cash flow ($111.29 Million). Explore capital reinvestment ratio of IGM Biosciences Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.98x
Free Cash Flow / Operating CF
Free Cash Flow
$109.46 Million
USD
Operating Cash Flow
$111.29 Million
USD
Capital Expenditures
$1.82 Million
USD
Annual Free Cash Flow Generation for IGM Biosciences Inc (None–None)
Year-by-year Free Cash Flow Generation Index for IGM Biosciences Inc. Check IGMS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).